"Mechanism-based Therapeutic Discovery in Breast Cancer"
At the conclusion of this activity, the participant will be able to:
- Attendees will be able to discriminate between subtypes of breast cancer and the importance of these subtypes in treating disease.
- Attendees will be able to explain the limitations of mTOR inhibition for cancer therapy and approaches used to overcome those limitations.
- Attendees will be able to describe the mechanisms of action of the epigenetic BET inhibitors in triple negative breast cancer.